ARTICLE | Company News
Coda Genomics, Viventia Biotech Inc. deal
January 1, 2007 8:00 AM UTC
The companies expanded a 2005 deal under which Coda uses its Translational Engineering technology to develop and optimize genes that Viventia uses to express an undisclosed antibody. Viventia will now...